First-in-human phase 1 trial of the safety and immunogenicity of a recombinant adenovirus serotype 5 HVR48 (rAd5HVR48) HIV-1 vaccine
暂无分享,去创建一个
J. Goudsmit | M. Seaman | M. Weijtens | R. Dolin | Ja Johnson | D. Barouch | R. Tucker | M. Pau | L. Baden | KH Krause | SR Walsh